Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT07622251
Starting soon Not applicable

The Effect of Exercise on Cognitive Functions in Individuals With Systemic Lupus Erythematosus

NCT07622251 · tracked via the Priya Life Science Turkey tracker
Sponsor
Istanbul Galata University
Phase
Not applicable
Started
2026-06-05
Last updated
2026-06-03

Condition(s) studied

System Lupus Erythematosus(SLE)

Investigational drug(s) / intervention(s)

Exercise

Exercise: Aerobic Exercise + video based games +calisthenics exercise

Study summary

Study Objective:

To examine the effect of aerobic exercise on disease activity and cognitive functions in patients diagnosed with SLE. Study Goals:

1. To conduct comprehensive pre- and post-treatment (after 12 weeks) evaluations of SLE patients included in the study, and to determine their disease activity and cognitive levels.
2. To apply aerobic exercise to SLE patients for three months.
3. To analyze the effects of the aerobic exercise program on disease activity and cognitive functions.

Eligibility

Sex
ALL
Min age
25 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Having been diagnosed with SLE at least one year prior according to the American Rheumatology Association (ACR) diagnostic criteria * Being between 25-65 years of age * Not having received a neuropsychiatric diagnosis * Having medication adjusted and being on stable medication for 3 months * Not being involved in a regular exercise program * Having a Mini Mental Test score lower than 26. Exclusion Criteria: * History of secondary rheumatic disease * Presence of active acute or chronic infection, * Body mass index (BMI) ≥ 30 kg/m2, * Acute renal failure, * Cardiac and pulmonary involvement, * Presence of musculoskeletal and joint disorders that prevent exercise testing, * Pregnancy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istanbul Galata University Istanbul Turkey (Türkiye)

More Istanbul Galata University trials in Turkey

Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity Starting soon
Evaluation of Validity and Reliability of the Turkish Translation of the Digital Health Readiness Questionaire in Different Chronic Diseases Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07622251 on ClinicalTrials.gov ↗ ← All trials in Turkey